Trial Details
RECRUITINGBasic Information
| Clinical ID | c139 |
|---|---|
| Identifier | NCT07113522 |
| Trial Title | A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Disease (IBD)|Ulcerative Colitis (UC)|Crohn's Disease |
| Interventions | DRUG: MT-501|DRUG: MT-201 |
Participant Information
| Sponsor | Mirador Therapeutics, Inc. |
|---|---|
| City | Birmingham |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-06-26 |
|---|---|
| Primary Completion Date | 2027-04-30 |
| Completion Date | 2028-02-04 |